evolocumab News
Latest articles and news about evolocumab on AXL Media.
Latest Articles
- Mass General Brigham Study Finds Intensive Cholesterol Treatment Cuts First-Time Heart Events by Thirty-One Percent in Diabetic Patients
Published: Mar 30, 2026
Section: Research
A new analysis from the VESALIUS-CV trial presented at ACC.26 reveals that the PCSK9 inhibitor evolocumab significantly benefits high-risk diabetic patients before they develop kno...
- New Trial Results Prove PCSK9 Inhibitors Reduce Major Cardiovascular Events by Thirty-One Percent in High-Risk Diabetic Patients
Published: Mar 30, 2026
Section: Research
A landmark subgroup analysis of the VESALIUS-CV trial presented at ACC.26 reveals that the cholesterol-lowering drug evolocumab provides significant protective benefits for diabeti...
- New Clinical Trial Reveals Cholesterol-Lowering Injection Reduces Major Heart Events by Thirty-One Percent in High-Risk Diabetic Patients
Published: Mar 30, 2026
Section: Medical News
A landmark subgroup analysis of the VESALIUS-CV trial presented at ACC.26 shows that the PCSK9 inhibitor evolocumab significantly benefits diabetic patients even before the develop...